Trademarkia Logo

Canada

C$
K & DESIGN
REGISTERED

on 23 Dec 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

KIRIN HOLDINGS KABUSHIKI KAISHA (ALSO TRADING AS KIRIN HOLDINGS COMPANY LIMITED)

10-2, Nakano 4-ChomeNakano-Ku, Tokyo

JP

Serial Number

1938698 filed on 2th Jan 2019

Registration Number

TMA1157723 registered on 23rd Dec 2022

Registration expiry Date

23rd Dec 2032

Correspondent Address

MARKS & CLERK

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

K & DESIGN

Trademark usage description

anti-epileptic pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; antiviral pharmaceutical preparations; pharmaceutical preparati Read More

Vienna Information


26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 19

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with inscriptions projecting beyond the circumferenceSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec inscriptions débordant la circonférence

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

Classification Information


Class [005]
Anti-epileptic pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; antiviral pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of gastrointestinal diseases, cancer, bacterial skin infections; human vaccines; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies, intestinal bacteria; veterinary vaccines; pharmaceutical preparations for the treatment of influenza, colds, physical disorder and fatigue; pharmaceutical preparations for maintaining a balance of skin flora and enhancing skin barrier functions; pharmaceutical preparations for treatment of anemia; pharmaceutical preparations for treatment of leukopenia; pharmaceutical preparations for mobilization of peripheral blood progenitor cell; pharmaceutical preparations for treatment of hyperphosphatemia; pharmaceutical preparations for treatment of hyperparathyroidism; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of leukemia; pharmaceutical preparations for treatment of influenza; pharmaceutical preparations for treatment of HIV; pharmaceutical preparations for treatment of myelodysplastic syndrome; pharmaceutical preparations for treatment of hepatitis virus infection; pharmaceutical preparations for treatment of autoimmune hepatitis; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; pharmaceutical preparations for treatment of hypophosphatemia; pharmaceutical preparations for improving wearing-off phenomenon in Parkinson's disease; stem cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes; cell culture mediums for medical and veterinary laboratory use; cell culture media for medical laboratory use; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; absorbent cotton; adhesive plasters; bandages for dressings; lacteal flour for babies; anti-oxidants for use as dietary supplements; dietary food supplements in the nature of ready-to-eat protein bars; dietary supplement drink mixes for general health and wellbeing; dietary supplements consisting of amino acids; dietary supplements consisting of minerals; dietary supplements consisting of vitamins; dietary supplements consisting primarily of iron; dietary supplements for body weight control; dietary supplements for controlling cholesterol; dietary supplements for general health and well-being; dietary supplements consisting of oligosaccharides; dietary supplements consisting of hop extracts for general health and well-being; dietary supplements consisting of matured hop extracts for general health and well-being; dietary supplements consisting of hop extracts for reducing cholesterol; dietary supplements consisting of matured hop extracts for reducing cholesterol; dietary supplements consisting of hop extracts for reducing body fat; dietary supplements consisting of matured hop extracts for reducing body fat; dietary supplements consisting of hop extracts for maintaining cognitive function; and dietary supplements consisting of matured hop extracts for maintaining cognitive function; dietary supplements consisting of lactic acid bacteria; diabetic fruit juice beverages adapted for medical purposes; electrolyte replacement beverages for medical purposes; malted milk beverages for invalids; medicated beverages in the nature of dietary supplements for colon detoxification; medicated beverages in the nature of dietary supplements for liver detoxification; dietetic sugar for medical purposes; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; dietetic substances consisting of oligosaccharides; dietetic substances consisting of hop extracts adapted for medical use for the prevention and treatment of iron deficiency and anaemia in humans; dietetic substances consisting of matured hop extracts adapted for medical use for the prevention and treatment of iron deficiency and anaemia in humans; dietetic substances consisting of hop extracts for reducing body fat; dietetic substances consisting of matured hop extracts for reducing body fat; dietetic substances consisting of hop extracts for maintaining cognitive function; and dietetic substances consisting of matured hop extracts for maintaining cognitive function; dietetic substances consisting of lactic acid bacteria; beverages for babies adapted for medical purposes; food for babies; glucose dietary supplements for animals; herbal and dietary supplements to aid in milk production in lactating animals; linseed dietary supplements for animals; mineral dietary supplements for animals; yeast dietary supplements for animals; oligosaccharides dietary supplements for animals; hop extracts-dietary supplements for animals containing cannabis for medicinal purposes; matured hop extracts-dietary supplements for animals containing cannabis for medicinal purposes; hop extracts-dietary supplements for animals for the prevention and treatment of iron deficiency and anaemia in animals; matured hop extracts-dietary supplements for animals for the prevention and treatment of iron deficiency and anaemia in animals; hop extracts-dietary supplements for animals for reducing body fat; matured hop extracts-dietary supplements for animals for reducing body fat; hop extracts-dietary supplements for animals for maintaining cognitive function; and matured hop extracts-dietary supplements for animals for maintaining cognitive function; lactic acid bacteria-dietary supplements for animals.


Classification kind code

11

Mark Details


Serial Number

1938698

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 17th Aug 2022
Advertised
Submitted for opposition 27
on 5th Jul 2022
Approval Notice Sent
Submitted for opposition 26
on 5th Jul 2022
Approved
Submitted for opposition 15
on 6th Dec 2021
Correspondence Created
Submitted for opposition 22
on 31st May 2021
Search Recorded
Submitted for opposition 20
on 31st May 2021
Examiner's First Report
Submitted for opposition 135
on 8th Nov 2019
Amendment to Application
Submitted for opposition 31
on 9th Jan 2019
Formalized
Submitted for opposition 1
on 3rd Jan 2019
Created
Submitted for opposition 30
on 2th Jan 2019
Filed